Published in Pain Res Manag on February 14, 2017
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol (2007) 3.87
Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06
Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev (2006) 2.59
Treatment of chronic non-cancer pain. Lancet (2011) 2.30
Mesenchymal stem cells: progress toward promise. Cytotherapy (2005) 2.19
The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther (2007) 2.05
A rat model of bone cancer pain. Pain (2002) 1.61
Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Nucl Med Biol (2011) 1.51
Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem (2009) 1.47
Development of a tumor-selective approach to treat metastatic cancer. PLoS One (2006) 1.46
Neuroinflammation and the generation of neuropathic pain. Br J Anaesth (2013) 1.22
Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. Neuroscience (2008) 1.15
Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke (2001) 1.11
Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J Cell Biochem (2005) 1.10
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci (2009) 1.07
Advances in cancer pain. Arch Neurol (1999) 1.04
Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant (1999) 1.03
Glia as a Link between Neuroinflammation and Neuropathic Pain. Immune Netw (2012) 1.02
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci (2011) 1.00
Neuropathic pain in cancer. Eur J Cancer (2008) 0.92
Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett (2007) 0.91
Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg (2007) 0.88
Intrathecal herpes simplex virus type 1 amplicon vector-mediated human proenkephalin reduces chronic constriction injury-induced neuropathic pain in rats. Mol Med Rep (2011) 0.85
Neuropathic pain in cancer. Br J Anaesth (2013) 0.84
Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin. Gene Ther (2014) 0.83
Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain. Cell Transplant (2002) 0.82
Bystander effect in glioma suicide gene therapy using bone marrow stromal cells. Stem Cell Res (2012) 0.80
Targeted cell reprogramming produces analgesic chromaffin-like cells from human mesenchymal stem cells. Cell Transplant (2013) 0.80
Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus. Cancer Gene Ther (2013) 0.77
Navigating the regulatory road to approval for cancer gene therapies. Cancer Gene Ther (2015) 0.76
Quality cancer care. Clin J Oncol Nurs (2013) 0.76